美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

ALVOTECH C/WTS (TO PUR COM)

0.3300

0.0000

成交量：- -

成交额：- -

市值：1,856.25万

市盈率：1.58

高：0.3300

开：0.3300

低：0.3300

收：0.3300

52周最高：3.00

52周最低：0.1527

股本：5,625.00万

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):0.2092

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

ALVOTECH C/WTS (TO PUR COM)

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.alvotech.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Alvotech于2021年8月23日根据卢森堡大公国法律注册成立。该公司是一家生物技术公司，由Robert Wessman创立，专注于为全球患者开发和制造生物仿制药。该公司通过提供高质量、具有成本效益的产品和服务，通过完全集成的方法和广泛的内部能力来寻求成为生物仿制药领域的全球领导者。该公司目前的产品线包含八种生物仿制药候选药物，旨在治疗自身免疫性疾病、眼部疾病、骨质疏松症、呼吸系统疾病和癌症。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ALVOW/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALVOW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALVOW\",,,,,undefined,":{"symbol":"ALVOW","market":"US","secType":"STK","nameCN":"ALVOTECH C/WTS (TO PUR COM)","latestPrice":0.33,"timestamp":1773946638813,"preClose":0.33,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":56250000,"eps":0.2092,"marketStatus":"交易中","change":0,"latestTime":"03-19 14:57:18 EDT","open":0.33,"high":0.33,"low":0.33,"amount":0,"amplitude":0,"askPrice":0.33,"askSize":100,"bidPrice":0.2501,"bidSize":240,"shortable":3,"etf":0,"ttmEps":0.2092,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773950400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.33,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALVOW\",,,,,undefined,":{"symbol":"ALVOW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":56250000,"dividePrice":0,"high":0.33,"amplitude":0,"preClose":0.33,"low":0.33,"week52Low":0.1527,"pbRate":"--","week52High":3,"institutionHeld":0,"latestPrice":0.33,"committee":0.411765,"eps":0.2092,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.2092,"open":0.33,"prevYearClose":0.6499,"prevWeekClose":0.33,"prevMonthClose":0.57,"prevQuarterClose":0.6499,"fiveDayClose":0.33,"twentyDayClose":0.3,"sixtyDayClose":0.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALVOW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-31","symbol":"ALVOW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1661918400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALVOW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALVOW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.alvotech.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0909},{"period":"3month","weight":-0.4407},{"period":"6month","weight":-0.6972},{"period":"1year","weight":-0.8226},{"period":"ytd","weight":-0.4922}],"compareEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.0298},{"period":"3month","weight":-0.0222},{"period":"6month","weight":-0.0034},{"period":"1year","weight":0.179},{"period":"ytd","weight":-0.03}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alvotech于2021年8月23日根据卢森堡大公国法律注册成立。该公司是一家生物技术公司，由Robert Wessman创立，专注于为全球患者开发和制造生物仿制药。该公司通过提供高质量、具有成本效益的产品和服务，通过完全集成的方法和广泛的内部能力来寻求成为生物仿制药领域的全球领导者。该公司目前的产品线包含八种生物仿制药候选药物，旨在治疗自身免疫性疾病、眼部疾病、骨质疏松症、呼吸系统疾病和癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.113065},{"month":2,"riseRate":0.833333,"avgChangeRate":0.151647},{"month":3,"riseRate":0,"avgChangeRate":-0.271505},{"month":4,"riseRate":0.2,"avgChangeRate":-0.008527},{"month":5,"riseRate":0.4,"avgChangeRate":0.045327},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013655},{"month":7,"riseRate":0.2,"avgChangeRate":0.004499},{"month":8,"riseRate":0.4,"avgChangeRate":-0.099509},{"month":9,"riseRate":0.6,"avgChangeRate":0.088631},{"month":10,"riseRate":0.6,"avgChangeRate":0.020112},{"month":11,"riseRate":0.4,"avgChangeRate":-0.104014},{"month":12,"riseRate":0.833333,"avgChangeRate":0.266402}],"exchange":"NASDAQ","name":"ALVOTECH C/WTS (TO PUR COM)","nameEN":"ALVOTECH C/WTS (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALVOW\",market:\"US\",,,undefined,":null}}